The National Pharmaceutical Pricing Authority (NPPA) has revised the ceiling prices of coronary stents. This revision of prices is effective from April 1, 2024. An order stipulating the revised prices was published on May 2, 2024.
This revision follows a series of notifications issued by the NPPA to regulate the pricing of these life-saving medical devices.
Coronary stents consist of tubes inserted into narrowed coronary arteries to improve blood flow to the heart. They are crucial for treating coronary artery disease.
The revision considers the Wholesale Price Index (WPI) for the year 2023.
- The new ceiling prices are:
- Bare Metal Stents: ₹10,509.79 per unit
- Drug Eluting Stents (DES): ₹38,267.18 per unit (including metallic DES and Bioresorbable Vascular Scaffold)
These prices are exclusive of Goods and Services Tax (GST). Manufacturers can revise their existing MRP (Maximum Retail Price) based on the new ceiling price and WPI increase.
The NPPA mandates retailers to display the updated price list on a conspicuous part of the premises
where he carries on business in a manner so as to be easily accessible to any person wishing to consult
the same.
Additionally, the manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon.
